- Posts:
- 0 (0 per day)
- Age:
- N/A
- Date Registered:
- May 26, 2024, 11:04:52 AM
- Local Time:
- June 17, 2024, 01:17:09 PM
- Last Active:
- May 26, 2024, 03:12:53 PM
Signature:
TP53-mutated severe myeloid leukaemia is owned by very poor final results. Eprenetapopt (APR-246) is a first-in-class, small-molecule p53 reactivator.